SEC Form 4 · accession 0000097745-26-000150
THERMO FISHER SCIENTIFIC INC. · TMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa P. Britt
Officer — Sr. VP and Chief HR Officer
Period of report
Aug 19, 2026
Accepted (ET)
Aug 20, 2026 · 4:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000097745
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2026 | M | 11,440 | $418.32 | A | 26,224 | D | |
| Common StockF1 | Aug 19, 2026 | S | 11,440 | $613.12 | D | 14,784 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $418.32 | Aug 19, 2026 | M | 11,440 | D | Mar 9, 2024 | Sep 9, 2027 | Common Stock | 11,440 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $613.09 to $613.49, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.